Showing 1141-1160 of 8875 for: Cochrane Systematic Reviews Back
- Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension
Cochrane Systematic Reviews, 8-Oct-2008
ACE inhibitors are widely prescribed for hypertension so it is essential to determine and compare their effects on blood pressure (BP), heart rate and withdrawals due to adverse effects (WDAE).
- Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension
Cochrane Systematic Reviews, 8-Oct-2008
Angiotensin receptor blockers (ARBs) are widely prescribed for hypertension so it is essential to determine and compare their effects on blood pressure (BP), heart rate and withdrawals due to adverse effects (WDAE).
- Blood pressure lowering efficacy of beta‐1 selective beta blockers for primary hypertension
Cochrane Systematic Reviews, 10-Mar-2016
Beta blockers are commonly used to treat hypertension. The blood pressure reading is the primary tool for physicians and patients to assess the efficacy of the treatment. The blood pressure lowering effect of beta-1 selective blockers is not known.
- Blood pressure lowering efficacy of beta‐blockers as second‐line therapy for primary hypertension
Cochrane Systematic Reviews, 20-Jan-2010
Beta-blockers are one of the more commonly prescribed classes of anti-hypertensive drugs, both as first-line and second-line.
- Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
Cochrane Systematic Reviews, 3-Mar-2016
Blood pressure is a commonly measured risk factor for non-fatal and fatal cardiovascular adverse events such as heart attacks and strokes. Clinical trials have suggested that coenzyme Q10, a non-prescription nutritional supplement, can effectively lower b
- Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension
Cochrane Systematic Reviews, 12-Aug-2009
Diuretics are widely prescribed for hypertension not only as a first-line drug but also as a second-line drug. Therefore, it is essential to determine the effects of diuretics on blood pressure (BP), heart rate and withdrawals due to adverse effects (WDAE
- Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension
Cochrane Systematic Reviews, 26-Aug-2015
Drugs with combined alpha and beta blocking activity are commonly prescribed to treat hypertension. However, the blood pressure (BP) lowering efficacy of this class of beta blockers has not been systematically reviewed and quantified.
- Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension
Cochrane Systematic Reviews, 28-Feb-2014
Beta-blockers are one of the classes of drugs frequently used to treat hypertension. Quantifying the blood pressure (BP) lowering effects of nonselective beta-blockers provides important information that aids clinical decision making.
- Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension
Cochrane Systematic Reviews, 27-Nov-2014
Partial agonists are a subclass of beta blockers used to treat hypertension in many countries. Partial agonist act by stimulating beta receptors when they are quiescent and blocking beta receptors when they are active. The blood pressure (BP) lowering eff
- Blood pressure lowering efficacy of potassium‐sparing diuretics (that block the epithelial sodium channel) for primary hypertension
Cochrane Systematic Reviews, 14-Nov-2012
Potassium-sparing diuretics, which block the epithelial sodium channel (ENaC), are widely prescribed for hypertension as a second-line drug in patients taking other diuretics (e.g. thiazide diuretics) and much less commonly prescribed as monotherapy. Ther
- Blood pressure lowering efficacy of renin inhibitors for primary hypertension
Cochrane Systematic Reviews, 20-Apr-2017
Hypertension is a chronic condition associated with an increased risk of mortality and morbidity. Renin is the enzyme responsible for converting angiotensinogen to angiotensin I, which is then converted to angiotensin II. Renin inhibitors are a new class
- Blood pressure targets for hypertension in older adults
Cochrane Systematic Reviews, 8-Aug-2017
Eight out of 10 major antihypertensive trials in older adults attempted to achieve a target systolic blood pressure (BP) less than 160 mmHg. Collectively these trials demonstrated benefit for treatment, as compared to no treatment, for an older adult with
- Blood pressure targets for hypertension in people with diabetes mellitus
Cochrane Systematic Reviews, 31-Oct-2013
When treating elevated blood pressure (BP), doctors often want to know what blood pressure target they should try to achieve. The standard blood pressure target in clinical practice for some time has been less than 140 - 160/90 - 100 mmHg for the general
- Blood pressure targets for the treatment of people with hypertension and cardiovascular disease
Cochrane Systematic Reviews, 18-Nov-2022
This is the third update of the review first published in 2017.
- Blood pressure targets in adults with hypertension
Cochrane Systematic Reviews, 17-Dec-2020
This is the first update of this review first published in 2009. When treating elevated blood pressure, doctors usually try to achieve a blood pressure target. That target is the blood pressure value below which the optimal clinical benefit is supposedly
- Blood pressure‐lowering efficacy of loop diuretics for primary hypertension
Cochrane Systematic Reviews, 22-May-2015
Antihypertensive drugs from the thiazide diuretic drug class have been shown to reduce mortality and cardiovascular morbidity. Loop diuretics are indicated and used to treat hypertension, but a systematic review of their blood pressure-lowering efficacy o
- Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
Cochrane Systematic Reviews, 29-May-2014
Hypertension is a modifiable cardiovascular risk factor. Although it is established that low-dose thiazides reduce mortality as well as cardiovascular morbidity, the dose-related effect of thiazides in decreasing blood pressure has not been subject to a r
- Blood pressure‐lowering efficacy of reserpine for primary hypertension
Cochrane Systematic Reviews, 21-Dec-2016
Many antihypertensive agents exist today for the treatment of primary hypertension (systolic blood pressure = 140 mmHg or diastolic blood pressure = 90 mmHg, or both). Randomised controlled trials (RCTs) have been carried out to investigate the evidence f
- Blood pressure‐lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack
Cochrane Systematic Reviews, 19-Jul-2018
Stroke is an important cause of death and disability worldwide. Since high blood pressure is an important risk factor for stroke and stroke recurrence, drugs that lower blood pressure might play an important role in secondary stroke prevention.
- Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease
Cochrane Systematic Reviews, 27-Jul-2020
Sickle cell disease is one of the commonest severe monogenic disorders in the world, due to the inheritance of two abnormal haemoglobin (beta globin) genes. Sickle cell disease can cause severe pain, significant end-organ damage, pulmonary complications,
